These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36525694)

  • 1. Design, synthesis, and biological evaluation of novel glutaminase 1 allosteric inhibitors with an alkane chain tail group.
    Chang X; Wang M; Zhang D; Zhang Y; Wang J; Li Z; Bian J; Xu X
    Eur J Med Chem; 2023 Jan; 246():115014. PubMed ID: 36525694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel glutaminase 1 allosteric inhibitor with 4-piperidinamine linker and aromatic heterocycles.
    Xu X; Chang X; Huang J; Zhang D; Wang M; Jing T; Zhuang Y; Kou J; Qiu Z; Wang J; Li Z; Bian J
    Eur J Med Chem; 2022 Jun; 236():114337. PubMed ID: 35428013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, structure-activity relationship studies, and evaluation of novel GLS1 inhibitors.
    Jo M; Koizumi K; Suzuki M; Kanayama D; Watanabe Y; Gouda H; Mori H; Mizuguchi M; Obita T; Nabeshima Y; Toyooka N; Okada T
    Bioorg Med Chem Lett; 2023 May; 87():129266. PubMed ID: 37011768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Enabled Discovery of Novel Macrocyclic Inhibitors Targeting Glutaminase 1 Allosteric Binding Site.
    Xu X; Wang J; Wang M; Yuan X; Li L; Zhang C; Huang H; Jing T; Wang C; Tong C; Zhou L; Meng Y; Xu P; Kou J; Qiu Z; Li Z; Bian J
    J Med Chem; 2021 Apr; 64(8):4588-4611. PubMed ID: 33792311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutaminase 1 plays a key role in the cell growth of fibroblast-like synoviocytes in rheumatoid arthritis.
    Takahashi S; Saegusa J; Sendo S; Okano T; Akashi K; Irino Y; Morinobu A
    Arthritis Res Ther; 2017 Apr; 19(1):76. PubMed ID: 28399896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamine metabolism via glutaminase 1 in autosomal-dominant polycystic kidney disease.
    Soomro I; Sun Y; Li Z; Diggs L; Hatzivassiliou G; Thomas AG; Rais R; Parker SJ; Slusher BS; Kimmelman AC; Somlo S; Skolnik EY
    Nephrol Dial Transplant; 2018 Aug; 33(8):1343-1353. PubMed ID: 29420817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Filamentous GLS1 promotes ROS-induced apoptosis upon glutamine deprivation via insufficient asparagine synthesis.
    Jiang B; Zhang J; Zhao G; Liu M; Hu J; Lin F; Wang J; Zhao W; Ma H; Zhang C; Wu C; Yao L; Liu Q; Chen X; Cao Y; Zheng Y; Zhang C; Han A; Lin D; Li Q
    Mol Cell; 2022 May; 82(10):1821-1835.e6. PubMed ID: 35381197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Glutaminase Inhibitor Compound 968 Exhibits Potent
    Guo H; Li W; Pan G; Wang C; Li D; Liu N; Sheng X; Yuan L
    Anticancer Agents Med Chem; 2023; 23(2):210-221. PubMed ID: 35570522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting GLS1 to cancer therapy through glutamine metabolism.
    Yu W; Yang X; Zhang Q; Sun L; Yuan S; Xin Y
    Clin Transl Oncol; 2021 Nov; 23(11):2253-2268. PubMed ID: 34023970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and pharmacological evaluation of 2-(1-(1,3,4-thiadiazol-2-yl)piperidin-4-yl)ethan-1-ol analogs as novel glutaminase 1 inhibitors.
    Yang T; Tian Y; Yang Y; Tang M; Shi M; Chen Y; Yang Z; Chen L
    Eur J Med Chem; 2022 Dec; 243():114686. PubMed ID: 36055003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes.
    Matre P; Velez J; Jacamo R; Qi Y; Su X; Cai T; Chan SM; Lodi A; Sweeney SR; Ma H; Davis RE; Baran N; Haferlach T; Su X; Flores ER; Gonzalez D; Konoplev S; Samudio I; DiNardo C; Majeti R; Schimmer AD; Li W; Wang T; Tiziani S; Konopleva M
    Oncotarget; 2016 Nov; 7(48):79722-79735. PubMed ID: 27806325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An updated patent review of glutaminase inhibitors (2019-2022).
    Wang D; Li X; Gong G; Lu Y; Guo Z; Chen R; Huang H; Li Z; Bian J
    Expert Opin Ther Pat; 2023 Jan; 33(1):17-28. PubMed ID: 36698323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting glutaminase 1 (GLS1) by small molecules for anticancer therapeutics.
    Chen Y; Tan L; Gao J; Lin C; Wu F; Li Y; Zhang J
    Eur J Med Chem; 2023 Apr; 252():115306. PubMed ID: 36996714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular targeting of glutaminase sensitizes ovarian cancer cells to chemotherapy.
    Masamha CP; LaFontaine P
    J Cell Biochem; 2018 Jul; 119(7):6136-6145. PubMed ID: 29633308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel allosteric glutaminase 1 inhibitors with macrocyclic structure activity relationship analysis.
    Lee EJ; Duggirala KB; Lee Y; Yun MR; Jang J; Cyriac R; Jung ME; Choi G; Chae CH; Cho BC; Lee K
    Bioorg Med Chem Lett; 2022 Nov; 75():128956. PubMed ID: 36038117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ErbB2 activation upregulates glutaminase 1 expression which promotes breast cancer cell proliferation.
    Qie S; Chu C; Li W; Wang C; Sang N
    J Cell Biochem; 2014 Mar; 115(3):498-509. PubMed ID: 24122876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Characterization of a Fluorescent Probe for GLS1 and the Application for High-Throughput Screening of Allosteric Inhibitors.
    Xu X; Kuang Z; Han J; Meng Y; Li L; Luan H; Xu P; Wang J; Luo C; Ding H; Li Z; Bian J
    J Med Chem; 2019 Nov; 62(21):9642-9657. PubMed ID: 31603674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of the Glutaminase II Pathway Contributes to Glutamate Production upon Glutaminase 1 Inhibition in Pancreatic Cancer.
    Udupa S; Nguyen S; Hoang G; Nguyen T; Quinones A; Pham K; Asaka R; Nguyen K; Zhang C; Elgogary A; Jung JG; Xu Q; Fu J; Thomas AG; Tsukamoto T; Hanes J; Slusher BS; Cooper AJL; Le A
    Proteomics; 2019 Nov; 19(21-22):e1800451. PubMed ID: 31231915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of glutaminase 1-mediated glutaminolysis improves pathological cardiac remodeling.
    Yoshikawa S; Nagao M; Toh R; Shinohara M; Iino T; Irino Y; Nishimori M; Tanaka H; Satomi-Kobayashi S; Ishida T; Hirata KI
    Am J Physiol Heart Circ Physiol; 2022 May; 322(5):H749-H761. PubMed ID: 35275762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutaminase and poly(ADP-ribose) polymerase inhibitors suppress pyrimidine synthesis and VHL-deficient renal cancers.
    Okazaki A; Gameiro PA; Christodoulou D; Laviollette L; Schneider M; Chaves F; Stemmer-Rachamimov A; Yazinski SA; Lee R; Stephanopoulos G; Zou L; Iliopoulos O
    J Clin Invest; 2017 May; 127(5):1631-1645. PubMed ID: 28346230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.